Literature DB >> 9658086

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.

A Sanchez1, Z Y Yang, L Xu, G J Nabel, T Crews, C J Peters.   

Abstract

The glycoproteins expressed by a Zaire species of Ebola virus were analyzed for cleavage, oligomerization, and other structural properties to better define their functions. The 50- to 70-kDa secreted and 150-kDa virion/structural glycoproteins (SGP and GP, respectively), which share the 295 N-terminal residues, are cleaved near the N terminus by signalase. A second cleavage event, occurring in GP at a multibasic site (RRTRR downward arrow) that is likely mediated by furin, results in two glycoproteins (GP1 and GP2) linked by disulfide bonding. This furin cleavage site is present in the same position in the GPs of all Ebola viruses (R[R/K]X[R/K]R downward arrow), and one is predicted for Marburg viruses (R[R/K]KR downward arrow), although in a different location. Based on the results of cross-linking studies, we were able to determine that Ebola virion peplomers are composed of trimers of GP1-GP2 heterodimers and that aspects of their structure are similar to those of retroviruses, paramyxoviruses, and influenza viruses. We also determined that SGP is secreted from infected cells almost exclusively in the form of a homodimer that is joined by disulfide bonding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658086      PMCID: PMC109803     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Glycosylation and oligomerization of the spike protein of Marburg virus.

Authors:  H Feldmann; C Will; M Schikore; W Slenczka; H D Klenk
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

2.  Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.

Authors:  T G Ksiazek; P E Rollin; P B Jahrling; E Johnson; D W Dalgard; C J Peters
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.

Authors:  P Chambers; C R Pringle; A J Easton
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

4.  Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.

Authors:  M B Ruiz-Argüello; F M Goñi; F B Pereira; J L Nieva
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  A synthetic peptide homologous to retroviral transmembrane envelope proteins depresses protein kinase C mediated lymphocyte proliferation and directly inactivated protein kinase C: a potential mechanism for immunosuppression.

Authors:  J Kadota; G J Cianciolo; R Snyderman
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

6.  Ebola virus: identification of virion structural proteins.

Authors:  M P Kiley; R L Regnery; K M Johnson
Journal:  J Gen Virol       Date:  1980-08       Impact factor: 3.891

7.  Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway.

Authors:  T Watanabe; K Murakami; K Nakayama
Journal:  FEBS Lett       Date:  1993-04-12       Impact factor: 4.124

8.  Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein.

Authors:  C Will; E Mühlberger; D Linder; W Slenczka; H D Klenk; H Feldmann
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Vaccinia-vectored expression of the rubella virus structural proteins and characterization of the E1 and E2 glycosidic linkages.

Authors:  A Sanchez; T K Frey
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

10.  Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus.

Authors:  M P Kiley; N J Cox; L H Elliott; A Sanchez; R DeFries; M J Buchmeier; D D Richman; J B McCormick
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

View more
  101 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Unconventional secretion of Ebola virus matrix protein VP40.

Authors:  Olivier Reynard; St Patrick Reid; Audrey Page; Mathieu Mateo; Nathalie Alazard-Dany; Hervé Raoul; Christopher F Basler; Viktor E Volchkov
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.

Authors:  Victoria M Wahl-Jensen; Tatiana A Afanasieva; Jochen Seebach; Ute Ströher; Heinz Feldmann; Hans-Joachim Schnittler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates.

Authors:  Gabriele Neumann; Thomas W Geisbert; Hideki Ebihara; Joan B Geisbert; Kathleen M Daddario-DiCaprio; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

8.  A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans.

Authors:  Alex S Powlesland; Tanja Fisch; Maureen E Taylor; David F Smith; Bérangère Tissot; Anne Dell; Stefan Pöhlmann; Kurt Drickamer
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

9.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.

Authors:  Carly Fleagle Chisholm; Taek Jin Kang; Miao Dong; Kasey Lewis; Madhuri Namekar; Axel T Lehrer; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2019-01-28       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.